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Abstract 
Functionalization of nanoparticles can significantly influence their properties and potential 
applications. Although researchers can now functionalize metal, metal oxide or organic 
polymer nanoparticles with a high degree of precision, controlled surface functionalization of 
nanoscale coordination polymer particles (CPPs) has remained a significant research 
challenge. This lack of methodology is perhaps one of the greatest roadblocks to the 
advancement of CPPs into high added-value drug delivery applications. Here we report 
having achieved this goal through stepwise formation and functionalization protocol. We 
fabricated robust nanoparticles with enhanced thermal and colloidal stabilities  by 
incorporation of carboxyl group and the surface carboxyl groups can be subsequently 
functionalized through well-known peptide coupling reactions. The set of chemistries that we 
employed as proof-of-concept enabled a plethora of new functional improvements for the 
application of CPPs as drug delivery carriers, including enhanced colloidal stabilities and the 
incorporation of additional functional groups such as PEG or fluorescent dyes that enabled 
tracking of their cellular uptake. Finally, we ascertained the cytotoxicity of the new CPP 
nanoparticles loaded with camptothecin to human breast adenocarcinoma (MCF-7). Efflux 
measurements show that the encapsulation of camptothecin enhances the potency of the drug 
in 6.5-fold and increases the drug retention within the cell. 
Introduction 
Miniaturization of coordination polymers (CPs)[1] to the nanoscale represents a novel class of 
highly customizable functional particles for drug-delivery on combining the rich diversity, 
chemistry and properties of coordination complexes to the advantages of nanomaterials.[2] 
Metal-organic frameworks (MOFs) have already been successfully used with this aim; MOFs 
allow control over the release cargo via modification of tunable pores with an exceptionally 
high surface area and therefore loading capacity. The crystalline nature of MOFs facilitates 
analyses of host–guest interactions and systematic drug encapsulation and release studies, as 
well as theoretical models.[3] In addition to MOFs, amorphous nanoscale coordination 
polymer particles (CPPs) have recently emerged as an effective alternative for the use of 
coordination polymer as drug delivery carriers. Since first being reported less than a decade 
ago,[4]  nanoscale CPPs have already shown their efficacy as encapsulation carriers,[5] 
sensors,[6] biopolymers,[7] drug delivery,[8] or theranostics[9] platforms. Nonetheless, the 
synthetic methodology for CPPs is in its fledgling stage. To date, there have not been any 
reports of methods to systematically control the surface functionality of CPPs or to master 
their modification at the nanoscale. This lack of methodology is perhaps one of the greatest 
roadblocks to the advancement of CPPs into high added-value medical applications. This is 
especially relevant for drug delivery applications, where significant advances involve the 
development of nanoparticles with specific surface functions and/or recognition chemicals 
that allow for an enhanced biological activity, imaging or stability. Although 
functionalization of metal or metal oxide,[10,11] MOFs [12] or pure organic polymer 
nanoparticles [13] can be achieved with a high degree of precision, this new family of metal-
organic coordination polymer particles remained unexplored. 
The most direct approach to achieve this goal is a priori the hierarchical assembly of 
nanoparticles using ligands with the desired functional group, a small fraction of which is 
expected to remain on the nanoparticle surface. However, this approach is limited by the 
unpredictable interplay of supramolecular interactions between ligands according to its 
chemical composition, steric constraints and bulk material properties, all of which can 
influence the final composition, stability and morphology of the nanoparticles. Thus, we 
envisioned the use of ligands bearing a reactive group that enables reproducible fabrication of 
nanoscale platforms and their post-synthetic modification. With this aim, herein we report the 
fabrication of CPPs incorporating ligands containing carboxyl groups (Figure 1 top), which 
have been shown to reinforce both the chemical and colloidal stability of the nanoparticles. 
Moreover, the surface carboxylates can be transformed into myriad functionalities through 
well-known condensation reactions, as schematically shown in Figure 1 down. The plethora 
of functionalities added range from polyethyleneglycol (PEG) to the incorporation of 
fluorescent dyes enabling tracking of their cellular uptake. Finally, we ascertained the 
successful cytotoxicity of the new CPP nanoparticles loaded with camptothecin to human 
breast adenocarcinoma cells (MCF-7). Efflux measurements showed a 6.5 fold increase in 
antitumoral activity of the encapsulate drug in comparison with free drug. This represents a 
notable evidence of the potential utility of these CPPs as chemotherapeutic nanomedicines 
with high uptake and in vitro activity under low dosing regimen.  
In a typical experiment, an aqueous solution of M(CH3COO)2•xH2O (where M stands for 
cobalt or iron) was added to an ethanolic solution combining two co-ligands: 3,4-
dihydroxycinnamic acid (dhc), used to introduce the carboxylic acid group on the structure, 
and 1,4-bis(imidazol-1-ylmethyl)benzene (bix), used as a counter ligand to induce 
polymerization. After vigorous stirring at room temperature a pale brown greenish precipitate 
was obtained for the cobalt complex (CPP0-Co) and a dark brown one for the iron sample 
(CPP0-Fe). The precipitate was then collected by centrifugation, washed several times with 
ethanol and dried under vacuum. SEM and TEM images revealed spherical nanoparticles 
with an average diameter of 110±17nm (CPP0-Co) or 94±11 nm (CPP0-Fe) (see Figure 2), 
as confirmed by dynamic light scattering (DLS). We were also able to control the average 
size by simply regulating the stirring rate (see Supporting Information S1). The reaction 
conditions were adjusted to assure a particle mean size close to 100 nm, an optimal range to 
be applied as drug delivery systems.[14] The chemical analysis data agreed with the general 
chemical formula [M(dhc)2(bix)]n.  X-ray Powder Diffraction data showed the typical pattern 
for an amorphous material. Fourier-transform infrared (FT-IR) spectra evidenced the 
coordination of the bix and catechol ligands to the metal and the permanence of the acidic 
group. Energy-Dispersive X-ray Spectroscopy confirmed the presence of the metal (Co or Fe) 
and of carbon, oxygen and nitrogen (see Supporting Information S2).  
   Chemical and colloidal stability. Surface carboxylic groups already enable control on the 
colloidal dispersion in water mainly by electrostatic repulsions, as already shown for different 
families of inorganic nanoparticles.[15] Zeta-potential measurements on CPP0-Co and CPP0-
Fe in aqueous buffer (~20 mM) at neutral pH (pH 7.3) gave values of –25.0 ± 8.2 mV and –
34.3 ± 9.7 mV, respectively. The resulting colloidal suspensions are stable for a few days. 
From here, the surface charge can be tuned by simply adjusting the pH of the buffer (see 
Figure 2e-f)—a feature which has been harnessed in other families of nanoparticles to 
modulate properties such as colloidal stability, toxicity and biocompatibility.[16] For instance, 
a pH increase to 9.0 led to a more negative zeta-potential value of -57.7 ± 6.2 mV (CPP0-Co) 
and -61.2± 5.1 mV (CPP0-Fe) and consequently, to less particle aggregation and therefore, 
more stable dispersions during several weeks due to an increase in Coulombic repulsions 
(increasing the pH further, to ~12.0, resulted in chemical decomposition as evidenced by a 
yellowish solution containing particles of inconsistent sizes). Contrariwise, decreasing the pH 
from 7.3 to 4.2 induced protonation of most of the surface carboxylate groups, leading to a 
zeta-potential value close to zero. Accordingly, the CPPs were highly prone to aggregate, 
which ultimately led to their precipitation. Interestingly, this aggregation and precipitation is 
reversible: bringing the pH back up enabled recovery of the stable colloidal suspension. 
Finally, when the pH was decreased to below 3.0 the CPPs rapidly decomposed. 
   Combined TGA/DSC and SEM experiments also evidence a considerable enhancement of 
the thermal and chemical stability most likely due to the formation of several hydrogen bonds 
within the core of the nanoparticle. CPP0-Co and CPP0-Fe nanoparticles begin to melt over 
105 ºC and decompose over 220 ºC, well over those found for other CPP families. For 
comparison purposes, model CPP1-Co nanoparticles obtained by replacement of dhc ligands 
by 3,4-di(tert-butyl) catechol groups were also studied. As expected, introduction of bulky 
tert-butyl groups without having the possibility to induced hydrogen bonds induces a 
decrease in the melting point down to ca. 60 ºC (see Supporting Information S2). Such 
difference in thermal stability can be translated to chemical robustness. Whereas CPP0 
nanoparticles are stable in water or PBS solution for several weeks, those of CPP1 remain 
only for a few days.   
Functionalization of CPP0 with the 6-aminofluorescein (ANF) fluorescent dye.  First 
attempts to couple the surface carboxyl groups of CPP0-Fe and CPP0-Co were done with a 
6-aminofluorescein dye in a water/ethanol solution at room temperature. After 24 h, stable 
ANF/CPP0-Fe and ANF/CPP0-Co nanoparticles were isolated without any morphological 
change concerning initial CPP0-Co (figure 3a). Successful coupling was indicated by the 
FTIR spectra; FT-IR spectrum lacked the characteristic NH2 stretching/bending bands (at 
3500-3350 and 1700-1500 cm-1) of the amine group from ANF and exhibited a less intense 
carboxylic acid C-OH stretching band (at 1300 cm-1) due to the carboxyl-amino surface 
coupling. The signal corresponding to the formation of the amide group is barely 
distinguishable, however, characteristic signals from 6-aminofluorescein are observed. (see 
Supporting Information S3). Fluorescence measurements on ANF/CPP0-Fe and ANF/CPP0-
Co revealed that the nanoparticles display a strong green luminescence (emission peak 
centered at ca. 520 nm) upon excitation at 490 nm, both in solution and in solid state (Figure 
3b). Such excitation is characteristic of the ANF group, though coordinative bonding induces 
its maximum absorbance to shift upon partial hybridization with the metal ion (see 
Supporting Information S3). In contrast, under identical conditions, CPP0-Fe and CPP0-Co 
did not emit any fluorescence. The concentration of ANF on the CPPs surface was calculated 
by absorbance measurements (see Experimental Section) taking as reference the absorbance 
spectra of the corresponding non-functionalized nanoparticles. This calculation was not 
conclusive in the case of ANF/CPP0-Fe, however for ANF/CPP0-Co a concentration of 
1.58•10-9 mol ANF per mg of nanoparticles was calculated. 
Cellular uptake of NPs. After functionalization with the fluorescent dye, we then monitored 
the uptake of the fluorescently labeled ANF/CPP0 nanoparticles in MCF-7 cells using 
confocal laser scanning microscopy (CLSM). After 24 h of incubation, orthogonal views of 
CLSM images (Figure 3c, X Z) clearly exhibited the localization of these nanoparticles inside 
the cells. In contrast, no fluorescence was detected in untreated (control) cells. The cellular 
uptake of these nanoparticles was also investigated quantitatively. MCF-7 cells were 
incubated with ANF/CPP0-Co (100 µg/mL) or ANF/CPP0-Fe (100 µg/mL) for 24 h, and 
then lysed in PBS-1% SDS. The fluorescently labeled CPPs inside of the cells were 
quantiﬁed by analyzing the cell lysate in a spectroﬂuorometer reader (extinction wavelength: 
490 nm; emission wavelength: 520 nm). The relative cellular internalization of ANF/CPP0-
Co was 27%, and of fluorescently labeled ANF/CPP0-Fe, 39%. Transport mechanism of 
CPPs through the cell membrane is not known yet; though most likely it takes place through a 
endocytosis pathway, consistent with reports on anionic carboxylated and hydroxyl 
terminated PAMAM dendrimers.[17] This should be the case of our negatively charged 
particles at physiological pH (7.4).   
Functionalization of CPP0 with polyethylene glycol (PEG). We also coupled the surface 
carboxyl groups of CPPs to amino-functionalized NH2-PEG chains (O-(2-
aminoethyl)polyethylene glycol 3,000) in a phosphate buffer solution (pH 7.4). The reaction 
afforded a colloidal suspension, which was centrifuged, and then washed several times with 
an ethanol/diethyl ether solution. The resulting PEG/CPP0-Fe and PEG/CPP0-Co solid was 
dried under vacuum. Successful coupling was indicated by the FTIR spectra of (see 
Supporting Information S4). As observed by SEM (Figure 4a-b), the new PEG/CPP0-Fe and 
PEG/CPP0-Co nanoparticles are 8 to 10% larger than the corresponding precursors CPP0-
Fe and CPP0-Co and exhibit a 15% larger hydrodynamic radius based on DLS 
measurements, which we attributed to the presence of the PEG groups. Moreover, the surface 
charge can be also tuned by simply adjusting the pH of the buffer. For PEG/CPP0-Fe, 
increasing the pH to 9.0 led to a decrease in zeta-potential (from -11.4 mV to -22.3 mV) and 
consequently, to less particle aggregation in water (Figure 4c) —a feature which has 
previously been exploited for CPP0-Fe and CPP0-Co. More interesting is the comparison of 
colloidal dispersions of PEG/CPP0 and non-functionalized CPP0 nanoparticles at different 
concentrations in a PBS phosphate buffer (1mg/mL and 5mg/mL). After 1 week the solutions 
containing CPP0-Fe nanoparticles had undergone notable sedimentation, whereas the 
PEG/CPP0-Fe dispersions remained much more stable, owing to the PEG groups (figure 
4d). Finally, the surface concentration of PEG groups was determined by 1H-NMR 
measurements (see Experimental Section). For this the integral ratios of PEG methylene 
protons obtained upon dissolution of the PEG/CPP0-Fe nanoparticles is compared with a 
calibration curve of blank PEG methylene protons measured at different concentrations 
resulting in a value of 8.42·10-3 mg (2.80•10-9 mol) of PEG per mg of nanoparticles, and a 
surface concentration of PEG chains around ∼13 pmol/cm2 (35% of the theoretical surface 
carboxyl groups; see Experimental Section). If compare the calculated PEG concentration 
with the corresponding ANF concentration in the surface of analogous CPPs we observed as 
increasing of 1.7 times the amount of PEG related to ANF. This difference can be due to 
different factors such as coupling reactivity, steric hindrance or others. Further studies will be 
necessary to elucidate the main factors that govern it.  
Cytotoxicity measurements. In order to investigate the cytotoxicity of the different 
nanoparticles on the MCF-7 breast cancer cells XTT assay was used. MCF-7 cells were 
treated during 24h with increasing doses of Fe and Co nanoparticles and the results indicate 
that MCF-7 cells retained more than 75% viability, in comparison with untreated cells, even 
at high nanoparticle concentrations (see Supporting Information S5). It could be suggested 
that the chemical composition of the nanoparticles and the low percentage of metal ions (less 
than 10% in mass) did not contribute to toxicity. Thus, nanoparticles showed no cytotoxicity 
and thus great potential to be drug carriers. 
Encapsulation and drug delivery. To evaluate de effectiveness of these nanoplatforms as 
nanocarriers and their therapeutic potential as drug delivey systems for cancer treatment, 
CPP0-Fe nanoparticles were used to encapsulate campothecin (CPT). By addition of an 
aqueous solution of Fe(CH3COO)2 to an ethanolic solution containing the mixture bix/dhc 
and the drug ([CPT] = 3.0 x 10-3 M) under stirring at room temperature, the resulting 
nanoparticles (CPT@CPP0-Fe) were obtained. Afterwards the nanoparticles were purified 
by centrifugation and washed several times with ethanol. This process was repeated until no 
fluorescence signal from non-encapsulated CPT was detected in the supernatant solution by 
fluorimetric measurements. Representative SEM and TEM images reveal the formation of the 
nanoparticles with a mean size of 112±19 nm and the entrapment of CPT was confirmed by 
both absorption and fluorescence measurements (Figure 5); encapsulation efficiency of ca. 
80% and drug loading capacity up to 18% in weight were obtained by absorption 
measurements with respect to the initial drug concentration used, and comparison with non-
loaded blank nanoparticles. 
   Under these conditions, the half maximal inhibitory concentration (IC50) for CPT@CPP0-
Fe was 2.79 ng and 1.16 ng CPT/ml, at 24h and 72h, respectively. The cytotoxicity effect of 
the free CPT in a MCF7 cellular culture at 24 h and 72 h under the same experimental 
conditions was also studied for comparison purposes. The half maximal inhibitory 
concentration (IC50) was 18.52 and 7.37 ng/ml at 24h and 72h, respectively. This represents 
an astonishing 6.5-fold drug efficacy increase upon encapsulation (Figure 5d). These 
excellent results have been attributed to higher intracellular levels of CPT arising from an 
increased cellular uptake of the drug upon encapsulation.  
Extrapolation to other compositions. Finally, to demonstrate that our new synthetic 
framework can be extrapolated to other reactive groups opening the possibility to 
systematically tune CPPs performance for drug delivery, we fabricated CPP platforms with 
ligands bearing a reactive aldehyde group. Following the methodology previously described 
but replacing the 3,4-dihydroxycinnamic acid (dhc) by the 3,4-dihydroxybenzaldehyde 
(dhba) ligand, amorphous spherical nanoparticles with an average diameter of 100±12 nm 
(CPP2-Fe) were obtained as confirmed by combined SEM, DLS experiments and X-ray 
Powder Diffraction experiments. Fourier-transform infrared (FT-IR) spectra evidenced the 
coordination of the bix and catechol ligands to the metal and the permanence of the aldehyde 
group. Energy-Dispersive X-ray Spectroscopy confirmed the presence of the metal (Fe) and 
of carbon, oxygen and nitrogen. Afterwards we coupled the surface aldehyde groups of 
CPP2-Fe to a 1-Pyrenebutyric hydrazide (PBH) dye in a ethanolic solution, in presence of 
acetic acid and heating at 80ºC. After 6 h, stable PBH/CPP2-Fe nanoparticles were isolated 
without any morphological change concerning initial CPP2. Successful coupling was 
indicated by the FTIR spectra (see Supporting Information S6). 
Fluorescence measurements on PBH/CPP2-Fe revealed that the nanoparticles display a 
strong luminescence (emission peak centered at ca. 410 nm) upon excitation at 347 nm, both 
in solution and in solid state, confirming the validity of our approach. 
 
Conclusion 
We fabricated robust nanoparticles by incorporation of carboxyl groups. The resulting 
nanoscale CPP exhibit three main advantages: I) they offer a highly robust platform 
reinforced by several supramolecular hydrogen bonds within the polymeric network, while 
retaining the morphological characteristics and encapsulation capacities, II) surface carboxyl 
groups allow for the systematic control over the colloidal dispersion of CPPs and III) the 
surface carboxylates can be transformed into myriad functionalities through well-known 
peptide coupling reactions, which is difficult to achieve by direct formation. This has been 
demonstrated via labeling with new bioactive functional groups (fluorescent dyes or PEG).  
We have also explored their use as drug delivery carriers. CPT@CPP0-Fe nanoparticles 
have shown a 6.5-fold increase efficacy with respect to the free CPT, affording formulations 
with low clinically relevant IC50s. Moreover, the relatively high load capacity of drugs such 
as CPT, their low cytotoxicity, the possibility to image the cell internalization by 
functionalization with fluorescent groups and the control of colloidal stability in aqueous 
dispersions provide very promising and non-developed nanoplatforms with applications on 
drug delivery. 
 
Experimental Section 
Experimental Solvents and starting materials were purchased from Sigma-Aldrich and used 
as received, without further purification, unless otherwise stated. 1,4-Bis(imidazol-1-
ylmethyl)benzene (bix) [18] and CPP1-Co nanoparticles [19] were synthesized according to a 
previously reported methods. 
   Synthesis of CPP0-Co and CPP0-Fe. 1,4-Bis(imidazol-1-ylmethyl)benzene (59 mg, 0.25 
mmol) and 3,4-dihydroxycinnamic acid (dhc, 90 mg, 0.5 mmol) were dissolved in 15 mL of 
ethanol. Under vigorous stirring (800 rpm) the solution was treated with an aqueous solution 
of either Co(CH3COO)2•4H2O (62.3 mg, 0.25 mmol in 2 mL H2O; for CPP0-Co) or 
Fe(CH3COO)2 (43.5 mg, 0.25 mmol in 2 mL H2O; for CPP0-Fe), which turned it either 
brownish-green or dark blue, respectively, and led to rapid form ation of a precipitate. After 
the solution was stirred at room temperature for 30 minutes, the precipitate was collected by 
centrifugation, and then washed with ethanol several times. The solvent was removed and the 
solid was dried under vacuum. SEM and TEM images of the resulting spherical nanoparticles 
showed a size distribution of 110±17 nm and 94±11 nm for CPP0-Co and CPP0-Fe 
respectively. C,H,N analysis (%) calcd for C32H28O8CoN4 : C 58.63, H 4.31, N 8.55; found: 
C 59.34, H 4.79, N 8.18. C,H,N analysis (%) calcd for C32H28O8FeN4: C 58.91, H 4.33, N 
8.59; found: C 59.48, H 4.92, N 8.40. FT-IR (ATR) CPP0-Co: ν =3412.5 (s), 3092.4 (s), 
1615.3 (s), 1585.2 (s), 1486.2 (m), 1396.4 (m), 1088.2 (m), 809.9 (m), 727.7 (m), 658.21 (m) 
cm-1. FT-IR (ATR) CPP0-Fe: ν = 3422.1 (s), 3101.3 (s), 1609.7 (s), 1478.6 (m), 1395.3 (m), 
1095.4 (m), 798.9 (m), 722.5 (m), 657.3 (m) cm-1. 
   Synthesis of CPP2-Fe. 1,4-Bis(imidazol-1-ylmethyl)benzene (59 mg, 0.25 mmol) and 3,4-
dihydroxybenzaldehyde (69 mg, 0.5 mmol) were firstly dissolved in 15 mL of ethanol. Under 
vigorous stirring (800 rpm), the solution was treated with an aqueous solution of 
Fe(CH3COO)2 (43.5 mg, 0.25 mmol in 2 mL H2O), which turned it light brown and led to 
rapid formation of a precipitate. After the solution was stirred at room temperature for 30 
minutes, the precipitate was collected by centrifugation, and then washed with ethanol several 
times. The solvent was removed and the solid was dried under vacuum. SEM and TEM 
images of the resulting spherical nanoparticles showed a size distribution of 100±12 nm. 
C,H,N analysis (%) calcd for C28H24O6FeN4 : C 59.17, H 4.26, N 9.86; found: C 59.49, H 
4.35, N 10.01; FT-IR (ATR): ν =2361.2 (m), 2335.3 (m), 1651.7 (m), 1570.6 (m), 1483.2(s), 
1434.4 (m), 1282.5 (s), 1102.5 (m), 948.4 (w), 821.4 (m), 750.3 (m), 640.1 (m) cm-1. 
   Synthesis of CPT@CPP0-Fe nanoparticles. These drug loaded spheres were obtained by 
addition of an aqueous solution (5 ml) of Fe(CH3COO)2 (109 mg, 0.625 mmol) to an 
ethanolic solution (25 ml) containing a mixture of bix (147.5 mg, 0.625 mmol), dhc (225 mg, 
1.25 mmol) and the drug CPT (3.0 x 10-3 M) under vigorous stirring at room temperature. 
The resulting encapsulated metal-organic polymer nanoparticles were purified by 
centrifugation and washed at least three times with ethanol to eliminate impurities and rest of 
the drug adsorbed on the nanoparticles surface. The encapsulated systems were dried and 
storage under inert atmosphere in the freeze. These nanoparticles are easily redispersable in 
different organic solvents, water or phosphate buffer.  
   Functionalization of CPP0-Co/Fe CPPs with 6-aminofluorescein (ANF): To a stirring 
dispersion of 30 mg of nanoparticles in 15 mL of H2O/EtOH (4:1) were added 5 mg (0.014 
mmol) of 6-aminofluorescein. After 10 minutes, EDC (10 mg, 0.05 mmol) and NHS (5.75 
mg, 0.06 mmol) were added, and the mixture was stirred at room temperature for 6 hours. 
The resulting particles were purified by centrifugation, and then washed with ethanol several 
times to remove any excess starting material (the total absence of any remaining, non-
attached dye in the supernatant solution was confirmed by the absence of any fluorescence 
signal). The precipitate was dried under vacuum overnight. 
   Functionalization of CPP2-Co/Fe CPPs with 1-Pyrenebutyric hydrazide (PBH): To a 
stirring dispersion of 8 mg of nanoparticles in 6 mL of ethanol were added 3 mg (0.017 
mmol) of 1-Pyrenebutyric hydrazide and one drop of acetic acid. The mixture was stirred at 
80ºC for 8 hours. The resulting particles were purified by centrifugation, and then washed 
with water and ethanol several times to remove any excess of starting material (the total 
absence of any remaining, non-attached dye in the supernatant solution was confirmed by the 
absence of any fluorescence signal). The precipitate was dried under vacuum overnight.  
   Functionalization of CPP0-Co/Fe CPPs with O-(2-aminoethyl)polyethylene glycol 
3.000 (NH2-PEG). Carboxyl-functionalized CCPs (30mg) were dispersed in 10 mL of 
phosphate buffer solution (PBS, 50 mM, pH 7.4). Subsequently, to activate the carboxylic 
acid groups, EDC (20 mg, 0.10 mmol) and NHS (11.5 mg, 0.13 mmol) were added at room 
temperature and the solution was kept for 2 h under continuous stirring. Afterwards, 100 mg 
of PEG prepared in 5 mL of PBS were added and the solution was stirring for 24 h at room 
temperature. The resulting nanoparticles were collected by centrifugation, washed with water 
and ethanol, and dried under vacuum.  
Characterization: Optical microscopy images were obtained with an Axio Observer Z-1 
(Zeiss) inverted optical microscope, equipped with an XY motorized sample holder. The light 
source is a high-pressure Hg steam lamp of short arc (HBO 103/2 of 100W). The microscope 
is equipped with different objectives (5x, 10x, 20x, 50x, 100x) as well as filters for 
fluorescence measurements (DAPI: exc. BP 365/12, emis. LP 397; Alexa Fluor 488: exc. BP 
450, emis. LP 515; and Alexa Fluor 546: exc. BP 540/12, emis. LP 590). Fluorescence was 
detected with an AxioCam HRc camera with a Sony CCD sensor (resolution: 1388 x 1040 
pixels = 1.4 Mpxl). SEM measurements were performed with a HITACHI S-570 operating at 
15 kV. The samples were prepared by drop casting of the corresponding dispersion on 
aluminum tape followed by evaporation of the solvent under room conditions. Before 
analysis the samples were metalized with a thin layer of gold, using a sputter coater (Emitech 
K550). Transmission electron microscopy (TEM) images were acquired with a Jeol JEM-
1400 microscope operating at 120 kV. The samples were prepared by casting a drop of the 
corresponding sample dispersion on a holey carbon copper grid, and then evaporating off the 
solvent under room temperature. Size distribution and surface charge of the nanoparticles 
were measured by DLS, using the Zetasizer Nano 3600 instrument (Malvern Instruments, 
UK), whose size range limit is 0.6 nm to 6 µm (5 nm to 10 µm for zeta-potential). Note: the 
diameter measured by DLS is the hydrodynamic diameter. The samples comprised aqueous 
dispersions of the nanoparticles in distilled water or in buffer. All samples were diluted to 
obtain an adequate nanoparticle concentration. The data reported are mean values for each 
sample, which were measured in quadruplicate. To study the influence of pH on zeta-
potential, the nanoparticles were dispersed in different PBS buffers (pH: 4.2, 7.3, 9.0 or 12.0). 
The IR spectra have been recorded using a Tensor 27 (Bruker) spectrophotometer equipped 
with a single-reflection diamond window ATR accessory (MKII Golden Gate, Specac). 
Powder XRD spectra were recorded at room temperature on a high-resolution texture 
diffractometer (PANalytical X’Pert PRO MRD) equipped with a Co-Kα radiation source (λ = 
1.7903Å) and operating in reflection mode. The solid samples were placed in an amorphous 
silicon oxide flat plate and measured directly. 
   Determination of ANF concentration on CPPo nanoparticles. The concentration of ANF 
on the surface was calculated using a solution containing 2 mg of ANF/CPP0 nanoparticles 
in 3ml of PBS by applying the Beer's Law (c = A / ε l); specifically molar extinction 
coefficient for 6-aminofluorescein εANF = 83,000. The absorbance signal of the attached 
ANF was obtained by deconvolution the spectra of the functionalized nanoparticles taking as 
reference the absorbance spectra of the corresponding non-functionalized nanoparticles. This 
calculation was easy for ANF/CPP0-Co nanoparticles, however the high dispersion of the 
particles and broad signal of ANF in ANF/CPP0-Fe make difficult to obtain a good result 
(see Supporting Information S3). Once the ANF concentration in the dispersion is calculated, 
the amount of fluorescent dye per mg of nanoparticles can be easily calculated. For 
ANF/CPP0-Co: [ANF]calc = 1.06•10-6 M; that match with 1.58•10-9 mol ANF per mg of 
nanoparticles. 
   Determination of attached PEG groups by 1H-NMR. In a sample experiment, 20 mg of 
dry PEG/CPP0-Fe nanoparticles was re-dispersed in deuterated methanol. Two drops of 
deuterated hydrochloric acid were added to the solution to afford the complete dissolution 
and demetalation of the coordination polymer. 1H-NMR spectra (250 MHz) were recorded on 
a Bruker Avance DRX-250 spectrometer with chemical shifts and integration relative to an 
external reference. The external reference consisted of 10 µL acetone dissolved into 0.5 mL 
of deuterated methanol in a WILMAD coaxial insert tube immersed in the 5 mm NMR 
sample tube (acetone chemical shift: 2.15 ppm). For the calibration curve, NH2-PEG (MW 
3000) with different known weights was dissolved in deuterated methanol, and the samples 
were characterized by NMR. The calibration curve was obtained by plotting the integral 
ratios of the PEG methylene protons (chemical shift: 3.25-3.60 ppm) against the external 
reference signal (see Supporting Information S7). By measuring the integral ratios of PEG 
methylene protons obtained from the dissolution of the coordination polymer respect to the 
same external reference, the average PEG concentration was obtained by comparison of the 
results with the calibration curve. The calculations afford an amount of 9.42·10-3 mg of PEG 
per mg of nanoparticles. The calculated surface area of the particles was then used to 
determine the surface concentration of PEG. By modeling the nanoparticles as perfect 
spheres of 100 nm size containing one –COOH group each ∼170Ǻ2 that correspond to the 
metal-metal separations in typical Co-bix complexes (between 12-14Ǻ), as extracted from 
different structural characterizations found in literature.[20] Thus it is possible to give an 
estimate of the expected maximum coverage of the surface by the PEG chains. So, this 
theoretical approximation affords a maximum concentration of carboxyl groups on the 
nanoparticles surface around ∼38 pmol/cm2. With the known surface area of the particles 
used, the surface concentration of PEG can be determined accordingly.[21] The calculated 
surface concentration of PEG obtained was ∼13 pmol/cm2 This translates to a 
functionalization level of 34% of the initial surface carboxyl groups, which is consistent with 
the estimated value (ca. 40%) obtained from zeta-potential studies by comparison of PEG 
functionalized and nonfunctionalized nanoparticles (see Supporting Information S7). 
Cytotoxicity assay. Human breast-cancer cells (MCF-7) were obtained from American Type 
Culture Collection (ATCC, Manassas, VA, USA). The cells were routinely cultured with 
DMEM F12 (Invitrogen) containing 10% heat-inactivated fetal bovine serum (FBS), at 37 ºC 
in a humidified (5%) CO2 atmosphere. The cytotoxicity of each type of nanoparticle was 
evaluated by the XTT (sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)-
carbonyl]-2H-tetrazolium inner salt) assay. MCF-7 cells were plated at a density of 5 x 103 
cells/well in 100 µL of culture medium in 96-well plates, and grown overnight. After 24 
hours incubation with different concentrations (0, 10, 25, 50, 100, or 200 µg/mL) of each 
nanoparticle, 20 uL of XTT was added. After 3 hours incubation, the absorbance (at 490 nm) 
of each well was measured by a microplate reader (Victor3). The relative cell viability (%) 
for each sample related to the control well was calculated. Each sample was tested in 
quadruplicate. 
   Cellular uptake of NPs. MCF-7 cells were seeded in a 35 mm glass-bottom culture dish 
(MatTek Corporation, Ashland, MA) at a density of 4 x 105 cells/well and incubated for 24 
hours. The cells were treated with one type of nanoparticle (either CPP0-Co, CPP0-Fe, 
PEG/CPP0-Fe or ANF/CPP0-Fe at 100 µg/mL), and then incubated for 24 hours at 37 °C. 
Prior to imaging, the cell membranes and nuclei were stained with Cell Mask™ Deep Red 
and Hoechst (Invitrogen), respectively, for 10 minutes. Fluorescence imaging was performed 
on a Leica TCS SP5 confocal fluorescence microscope. 
   The intracellular accumulation of ANF/CPP0-Fe was also quantified by fluorescence. 
Before the cell uptake experiments, MCF-7 cells were plated into six-well plates at a density 
of 4 x 105 cells/well and incubated overnight. The medium from each well was replaced with 
1 mL of medium containing ANF/CPP0-Fe nanoparticles. After 24 hours of nanoparticle 
exposure, the medium was removed, and the attached cells were washed and trypsinized, and 
the cell pellets were lysed with PBS 1% SDS. The lysates were analyzed in a Jasco FP-8200 
spectrofluorometer (excitation: 490 nm; emission: 520 nm). Cellular uptake (%) was 
calculated from the ratio of fluorescein concentration after treatment to that before treatment. 
   Anticancer activity of CPT@CPP0-Fe nanoparticles. The anticancer activity of 
CPT@CPP0-Fe nanoparticles was measured by the XTT assay using free CPT as a control . 
After incubating MCF-7 breast cancer cells with free CPT or CPT@CPP0-Fe nanoparticles 
(1, 2.5, 5, 7.5, 10, 25, 50 and 100 ng/mL) for 24 or 72h, 20 uL of XTT was added. After 3 h 
incubation, the cell viability was quantified using a microplate reader (Victor3). For IC50 
calculations, survival data were evaluated by variable slope curve-fitting using Prism 4.0 
software (GraphPad, San Diego, CA). 
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Figure captions 
 
Figure 1. (Top) Schematic of the formation of polymeric chains and confinement into a 
nanostructure by fast precipitation. (Bottom) Schematic of the functionalization of 
nanoparticles containing carboxyl groups on the surface with different species containing 
amino groups mediated by carbodiimine coupling reaction. 
 
 
 Figure 2. SEM images of a) CPP0-Co and b) CPP0-Fe nanoparticles showing good 
homogeneity and narrow size distribution; c) Solid samples and (d) water dispersions of 
CPP0-Co (pale brown) and CPP0-Fe (dark brown); e) Zeta-potential values for CPP0-Co 
(green dots) and CPP0-Fe (blue dots) at different pHs; f) DLS size dispersion measurements 
for CPP0-Co (green) and CPP0-Fe (blue) at different pHs. 
 Figure 3. a) SEM image of ANF/CPP0-Fe nanoparticles (inset: image of fluorescence 
microscopy); b) Normalized absorption (red) and emission (pink) spectra for the 6-
aminofluorescein attached to the ANF/CPP0-Fe surface; c) Confocal laser scanning 
microscopy images of the internalized fluorescent nanoparticles (ANF/CPP0-Fe). 
 Figure 4. SEM images of PEG/CPP0-Fe (a) and (b) PEG/CPP0-Co nanoparticles; c) Zeta-
potential measurements of the PEG-functionalized nanoparticles (PEG/CPP0-Co and 
PEG/CPP0-Fe) and the corresponding non-functionalized nanoparticles (CPP0-Co and 
CPP0-Fe). The decrease in free surface carboxylic groups after coupling with amino-PEG 
makes the zeta-potential less negative, and the value correlates to the concentration of PEG 
chains on the surface; d) Stability of colloidal dispersions of CPP0-Fe and PEG/CPP0-Fe at 
different concentrations in PBS after 1 week: 1mg/ml (left) and 5mg/ml(right). PEG is shown 
to improve the colloidal stability in PBS. 
 
 
 
 
 
 Figure 5. a) SEM image of CPT@CPP0-Fe nanoparticles; b)  Fluorescence optical 
microscope images of CPT@CPP0-Fe spheres collected at λexc = 355 nm (inset: digital 
zoom image); c) Normalized absorption and emission spectra for CPT 
(absorption:blue/emission:green) and CPT@CPP0-Fe (absorption:black/emission:red); d) 
Cytotoxic effect of CPT@CPP0-Fe nanoparticles and comparison with free CPT at 24h 
(left) and 72h (right). Solid dots correspond to free drug and empty dots correspond to 
encapsulated CPT. 
 
 
 
 
Text for the Table of Contents 
Multifunctional CPPs: Robust and biocompatible coordination polymer nanoparticles with 
enhanced thermal and colloidal stabilities were obtained by incorporation of carboxyl groups 
on the amorphous structure. The surface carboxyl groups can be subsequently functionalized 
generating a multifunctional nanoplatform for theranostic applications (drug delivery & 
imaging). 
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